Representatives from five Asian countries shared local experiences and current protocols for pharmacotherapy in treating patients with COVID-19 at a recent Asian Young Pharmacists' Group (AYPG) webinar.
The coronavirus has been spreading at a frantic pace, isolating families and snuffing out lives. As hunger and emotional contagion grip the nations, the hope of a containment also dims. No one has seen this enemy coming – the world has underestimated COVID-19.
Dr Dariusz P. Olszyna, a senior consultant at the Division of Infectious Diseases, National University Hospital, Singapore, speaks to Roshini Claire Anthony on the importance of early detection to prevent the spread and complications related to sexually-transmitted infections (STIs).
How does it feel to be told one has contracted HIV? How equipped are doctors when breaking the news to a patient that he or she has been diagnosed with HIV? Are we able to provide people living with HIV (PLHIV) the counselling and skills required to take them through this difficult period of life? MIMS Doctor speaks to Dr Julian Hong, a general physician practicing in Singapore, about the challenges faced by both patients and doctors when faced with the difficult topic of HIV.
Assoc Prof Philip Eng, senior consultant respiratory physician at Mt Elizabeth Hospital in Singapore, shares his insights with Pearl Toh on diagnosing and managing pneumonia in the primary care setting.
Dr Michael Lim, a senior consultant at the Paediatric Pulmonary and Sleep Division, National University Hospital, Singapore, speaks to Roshini Claire Anthony on the rare disease that is cystic fibrosis.
Multidrug-resistant organisms (MDROs) are frequently defined as bacteria with resistance to three or more classes of antimicrobials. Common examples include methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum beta-lactamases (ESBL)–producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae (CRE) and vancomycin-resistant Enterococci (VRE). The challenges of managing these infections are illustrated in the following two cases.
At the recent 4th National Aids Conference, Dr Charles Hicks, Senior Global Medical Director, ViiV Healthcare, US, spoke about the evolution of HIV care and how future advancements will impact the lives of persons living with HIV. Hicks, who is only recently joined ViiV Healthcare, said the cure for HIV is still likely far in the future. In the meantime, the only option is antiretroviral therapy (ART). However, despite the absence of a cure, the outlook for patients living with HIV has improved by leaps and bounds since the first antiretroviral zidovudine (AZT) was released.
Dr Indumathi Venkatachalam, a consultant at the Department of Infectious Diseases, Singapore General Hospital, speaks to Roshini Claire Anthony on how GPs can help ensure early detection of tuberculosis (TB).
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
Sodium–glucose cotransporter-2 (SGLT-2) inhibitors increase the risk for diabetic ketoacidosis (DKA) by almost threefold, with molecule-specific analyses suggesting a class effect, according to a study.
In the first year following percutaneous coronary intervention for acute coronary syndrome, ticagrelor and prasugrel cuts the risk of gastrointestinal (GI) bleeding by more than 30 percent compared with clopidogrel, as shown in a large real-world study.